MorphoSys AG Sustainability Reports
MorphoSys AG is a biopharmaceutical company that develops innovative cancer therapies, focusing primarily on hematology and oncology diseases.
Sector: Professional & technical services
Country: Germany
Exchange: OTC Markets
LEI: 529900493806K77LRE72
FIGI: BBG001SC07V0
No reports are currently available in our catalogue.